<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
MGC Pharmaceuticals Limited said it achieved record sales in its June quarter, boosted by higher sales of its phytocannabinoid products. In its quarterly results for the three months ended June 30, the developer of phytocannabinoid-derived medicines reported revenues of $945,000, of which $665,000 had come from its phytocannabinoid medicines, a 34% increase quarter-on-quarter, while $280,000 in revenue was recognised for its ArtemiC medical spray.
...read full article on Proactive Investors
